BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2014
View Archived Issues
Novel pan tyrosine kinase receptor inhibitor identified for the treatment of cancer
Read More
RXi Pharmaceuticals updates on phase II program of RXI-109 in scar recurrence prevention
Read More
Report of phase I evaluation of a STAT3 ASO for hepatocellular carcinoma
Read More
Takeda describes PDE10A inhibitor TAK-063
Read More
Phase I study initiated for ProMetic IV plasminogen
Read More
SOV Therapeutics' oral testosterone undecanoate meets phase IIb study endpoints
Read More
Pfizer starts phase II trial of anti-myostatin antibody in DMD
Read More
Further phase III data reveal efficacy of LCZ-696 in hypertension and heart failure
Read More
Bayer presents novel TTK inhibitors for cancer
Read More
NESP approved for anemia with myelodysplastic syndromes in Japan
Read More
Kyowa Hakko Kirin receives additional indication approval for Poteligeo in Japan
Read More
Prima BioMed completes acquisition of Immutep
Read More
Kadcyla fails to show superiority to Herceptin plus taxane therapy in untreated breast cancer
Read More
Polaris' ADI-PEG20 receives E.U. orphan drug status for MPM
Read More
Researchers report phase I results on taselisib in breast cancer
Read More
Medeia Therapeutics discloses new cytoprotectants
Read More
Johns Hopkins University patents novel aptamers for sickle cell anemia
Read More
HCV treatment designed by French and U.S. organizations
Read More
European orphan drug designation for Halozyme's PEGPH-20 in pancreatic cancer
Read More
FDA approves Lynparza, and companion diagnostic, for germline BRCA-mutated advanced ovarian cancer
Read More
EMA committee recommends approval of Xadago to treat mid- to late-stage Parkinson's disease
Read More
CHMP backs approval of Orexigen's naltrexone/bupropion for weight management
Read More
U.S. approval for Cubist's ceftolozane/tazobactam for cUTI and cIAI
Read More
FDA approves Rapivab for acute uncomplicated influenza
Read More
Intravenous administration of Erwinaze obtains U.S. approval
Read More